+7 (343) 270-75-00

          info@uphc.ru

News

On September 26, 2024, TASS hosted an expert discussion in the format of a federal teleconference Moscow-St. Petersburg-Ekaterinburg-Novosibirsk-Vologda-Anapa, dedicated to discussing the role, reasons and mechanisms for stimulating In Ekaterinburg, Alexander Petrov, the Chairman of the Board of Directors of Medsintez Plant LLC, told the participants about Triazavirin, an innovative domestic antiviral drug, as a success case of private investment in science.

60 leading Russian reproductologists visited the pharmaceutical company Medsintez Plant in Novouralsk on September 4, 2024. This event was timed to coincide with the celebration of the 3rd anniversary of the opening of the production workshop for biotechnological substances for the reproductive health of women, as well as the Annual International Conference «Reproductive Technologies Today and Tomorrow» in Ekaterinburg. Leading experts and conference speakers visited the production of the first Russian follitropin alpha for the treatment of human infertility, Primapur®.

In 2024, the Medsintez Plant in collaboration with Tonghua Anrate Biopharmaceutical Co. launched the production of the substance and finished dosage forms of the world's first registered drug of recombinant human albumin. The drug was obtained using Pichia Pastoris cells by the recombinant DNA technology.

The Medsintez Plant has participated in an international business meeting with the delegation from the United Arab Emirates as part of the INNOPROM 2024 business program in Ekaterinburg. The meeting with representatives of the national Ministry of Industry, pharmaceutical and medical industries of the UAE was organized by the Ministry of Industry and Trade of the Russian Federation. The meeting was attended by the Deputy Minister of Industry and Advanced Technology of the UAE, representatives of Globalpharma, SayGen, Hayat Biotech, Abu Dhabi Medical Devices.

OOO "MO «Otdel Meditsinskoi Tekhniki»

   

The company «Otdel Meditsinskoi Tekhniki» has been operating in the medical market for more than 20 years, the company employs more than 350 employees, the area of operating production and storage facilities is 4000 m2, the area under construction in the Titanium Valley, Special Economic Zone is 16000 m2. It operates its own production of medical and office furniture. As part of import substitution, the development of a high-tech functional bed was completed, a Registration Certificate and permit to use in health care institutions were obtained.

In 2017, mass production of functional beds was started.

In 2019, the development of projects began to launch the manufacture of plastic medical products: vacuum systems for blood sampling, breathing circuits and filters.

In 2022, the construction of a production building for the manufacture and sale of medical devices began on the territory of the Titanium Valley SEZ.

 

35, Yasnaya St., Ekaterinburg, 620102

Tel.: (343) 311-22-19,

e-mail: omt@omt-ural.ru

www.omt-ural.ru